JP5196416B2 - Limnocitruslittoralis抽出物を含有する化粧料組成物 - Google Patents
Limnocitruslittoralis抽出物を含有する化粧料組成物 Download PDFInfo
- Publication number
- JP5196416B2 JP5196416B2 JP2007160836A JP2007160836A JP5196416B2 JP 5196416 B2 JP5196416 B2 JP 5196416B2 JP 2007160836 A JP2007160836 A JP 2007160836A JP 2007160836 A JP2007160836 A JP 2007160836A JP 5196416 B2 JP5196416 B2 JP 5196416B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- composition according
- composition
- skin
- cosmetic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims description 79
- 239000000203 mixture Substances 0.000 title claims description 71
- 239000002537 cosmetic Substances 0.000 title claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 244000155376 Limnocitrus littoralis Species 0.000 claims description 23
- 102000008186 Collagen Human genes 0.000 claims description 21
- 108010035532 Collagen Proteins 0.000 claims description 21
- 229920001436 collagen Polymers 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 230000002757 inflammatory effect Effects 0.000 claims description 13
- 230000001575 pathological effect Effects 0.000 claims description 13
- 208000024891 symptom Diseases 0.000 claims description 13
- 238000003786 synthesis reaction Methods 0.000 claims description 13
- 230000009759 skin aging Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 9
- 230000035876 healing Effects 0.000 claims description 8
- 239000013543 active substance Substances 0.000 claims description 7
- 206010039897 Sedation Diseases 0.000 claims description 5
- 230000032683 aging Effects 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 230000036280 sedation Effects 0.000 claims description 5
- 230000004936 stimulating effect Effects 0.000 claims description 5
- 230000037303 wrinkles Effects 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 208000003251 Pruritus Diseases 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 claims description 3
- 208000010201 Exanthema Diseases 0.000 claims description 3
- 229940087168 alpha tocopherol Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 238000004042 decolorization Methods 0.000 claims description 3
- 201000005884 exanthem Diseases 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 206010037844 rash Diseases 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- 239000002076 α-tocopherol Substances 0.000 claims description 3
- 235000004835 α-tocopherol Nutrition 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000001624 sedative effect Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 206010016334 Feeling hot Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010040954 Skin wrinkling Diseases 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 36
- 241000207199 Citrus Species 0.000 description 12
- 235000020971 citrus fruits Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 230000036542 oxidative stress Effects 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 150000003180 prostaglandins Chemical class 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 230000037307 sensitive skin Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000276331 Citrus maxima Species 0.000 description 3
- 235000001759 Citrus maxima Nutrition 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229960000905 indomethacin Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000035824 paresthesia Diseases 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000003578 releasing effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 206010006784 Burning sensation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- WECIKJKLCDCIMY-UHFFFAOYSA-N 2-chloro-n-(2-cyanoethyl)acetamide Chemical compound ClCC(=O)NCCC#N WECIKJKLCDCIMY-UHFFFAOYSA-N 0.000 description 1
- 240000000981 Citrus hystrix Species 0.000 description 1
- 235000002320 Citrus hystrix Nutrition 0.000 description 1
- 241000190409 Citrus nobilis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 235000017102 Citrus x nobilis Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 206010046793 Uterine inflammation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000399 hydroalcoholic extract Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000005550 inflammation mediator Substances 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000010831 paired-sample T-test Methods 0.000 description 1
- -1 palmitoyl lecithin Chemical compound 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
I:Citrus maxima(Burm. Ex Rumph.)Merr.
II:Citrus aurentifolia(Christm.)Swingle
III:Citrus nobilis(Lour.)
IV:Citrus hystrix(DC.)
V:Citrus reticulata(Blanco.)
参照皮膚(酸化的ストレスなし、且つ未処理)
皮膚+酸化的ストレス(対照皮膚)
皮膚+酸化的ストレス+本発明に係るLimnocitrus littoralisの試験抽出物
その後、D7に、様々な分析のため皮膚培養を停止した。
・参照皮膚
・UVA及びUVBで実験的に老化させた皮膚(対照皮膚)
・皮膚+UVA/UVB+本発明のLimnocitrus littoralisの抽出物
Claims (20)
- 局所適用に適合し、化粧品として許容される賦形剤中に、アルコール又は水性アルコール抽出溶媒によって得られるLimnocitrus littoralisの抽出物を活性作用物質として含むことを特徴とする化粧料組成物。
- 前記抽出物が、Limnocitrus littoralisの地上部から得られることを特徴とする、請求項1に記載の組成物。
- 前記抽出物が、Limnocitrus littoralisの葉から得られることを特徴とする、請求項2に記載の組成物。
- 前記抽出溶媒が、C1〜C5モノアルコール及びC2〜C5グリコールからなる群より選択されることを特徴とする、請求項1〜3のいずれか1項に記載の組成物。
- 前記抽出溶媒が、エタノール、ブチレングリコール並びにエタノール/水及びブチレングリコール/水の混合液からなる群より選択されることを特徴とする、請求項1〜4のいずれか1項に記載の組成物。
- 前記抽出溶媒が、エタノール又は50%以下の水を含むエタノール/水の混合液であることを特徴とする、請求項5に記載の組成物。
- 前記抽出溶媒が、ブチレングリコールであることを特徴とする、請求項1〜5のいずれか1項に記載の組成物。
- 前記抽出溶媒中で溶液状態にある前記抽出物を、固形部分を除去するために固液分離工程に付すことを特徴とする、請求項1〜7のいずれか1項に記載の組成物。
- 前記抽出物を脱色工程に付すことを特徴とする、請求項1〜8のいずれか1項に記載の組成物。
- 組成物の総重量に対して10 −4 〜5重量%の間のLimnocitrus littoralisの乾燥抽出物を含むことを特徴とする、請求項1〜9のいずれか1項に記載の組成物。
- アルファ−トコフェロール、アスコルビン酸及びそれらのエステルからなる群より選択される酸化防止剤の少なくとも一つをさらに含むことを特徴とする、請求項1〜10のいずれか1項に記載の組成物。
- クリーム、ゲル、ローション、スティック、アイシャドウ又はメークアップファンデーションの形態で提供されることを特徴とする、請求項1〜11のいずれか1項に記載の組成物。
- 無水の形態であることを特徴とする、請求項1〜11のいずれか1項に記載の組成物。
- 前記抽出物が、ブチレングリコールの重量に基づいて0.05〜5重量%の前記乾燥抽出物を含むブチレングリコール溶液になるように添加されることを特徴とする、請求項1〜13のいずれか1項に記載の組成物。
- 化粧料組成物における、又は化粧料組成物の製造を目的とした、炎症性起源の非病理学的皮膚症状の治癒のための化粧料特性を鎮静作用によって当該化粧料組成物に与える活性作用物質としての、請求項1〜10のいずれか1項に記載の抽出物の使用。
- 熱又は灼熱の感覚、発疹、引張、掻痒及び刺痛からなる群より選択される炎症性起源の非病理学的皮膚症状を鎮静化するために前記化粧料組成物を用いることを特徴とする、請求項15に記載の使用。
- 化粧料組成物における、又は化粧料組成物の製造を目的とした、コラーゲン合成を刺激するための薬剤としての、請求項1〜10のいずれか1項に記載の抽出物の使用。
- 内因性及び/又は光誘導性の皮膚老化の影響を予防及び/又は治癒するために当該組成物を用いることを特徴とする、請求項17に記載の使用。
- 炎症性起源の非病理学的皮膚症状の鎮静化、並びに/又は内因性及び/若しくは光誘導性の老化の影響の予防及び/若しくは治癒のための、請求項1〜14のいずれか1項に記載の化粧料組成物であって、当該組成物が皮膚に適用されるように用いられる、組成物。
- シワ対策の手入れのための、請求項19に記載の組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0652784 | 2006-07-04 | ||
FR0652784A FR2903310B1 (fr) | 2006-07-04 | 2006-07-04 | Composition cosmetique contenant un extrait de limnocitrus littoralis |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008013553A JP2008013553A (ja) | 2008-01-24 |
JP5196416B2 true JP5196416B2 (ja) | 2013-05-15 |
Family
ID=37890783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007160836A Expired - Fee Related JP5196416B2 (ja) | 2006-07-04 | 2007-06-19 | Limnocitruslittoralis抽出物を含有する化粧料組成物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7527813B2 (ja) |
JP (1) | JP5196416B2 (ja) |
KR (1) | KR101315160B1 (ja) |
CN (1) | CN101099719A (ja) |
DE (1) | DE102007026156B4 (ja) |
FR (1) | FR2903310B1 (ja) |
GB (1) | GB2439793B (ja) |
IT (1) | ITTO20070462A1 (ja) |
RU (1) | RU2007121769A (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008052520A1 (de) * | 2008-10-21 | 2010-04-22 | Cognis Ip Management Gmbh | Kosmetische und/oder pharmazeutische Zubereitungen |
FR2943535B1 (fr) * | 2009-03-31 | 2011-08-12 | Lvmh Rech | Nouvelle utilisation d'un extrait vegetal obtenu a partir d'au moins une plante appartenant au genre citrus, ou un hybride issu du croisement d'especes vegetales dont l'une au moins appartient au genre citrus. |
FR2943542B1 (fr) * | 2009-03-31 | 2012-05-25 | Lvmh Rech | Methode de soin cosmetique anti-age par stimulation de l'activite de l'aconisate mitochondriale. |
US20110081430A1 (en) * | 2009-10-02 | 2011-04-07 | Simarna Kaur | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER |
EP2619159A1 (en) | 2010-09-24 | 2013-07-31 | Total Research & Technology Feluy | Production of isoprene from iso-butanol |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5310551A (en) * | 1976-07-15 | 1978-01-31 | Masakuni Kanai | Sludge treating method |
JP3195047B2 (ja) | 1992-05-13 | 2001-08-06 | 同和鉱業株式会社 | 美白化粧料 |
JP3292869B2 (ja) | 1992-09-01 | 2002-06-17 | アサヒビール株式会社 | ヒアルロニダーゼ阻害剤 |
JPH11209224A (ja) | 1998-01-22 | 1999-08-03 | Yuriko Sugiyama | 日本酒を用いた化粧水 |
KR100369578B1 (ko) * | 1998-03-20 | 2003-03-17 | 주식회사 태평양 | 주름개선효과가있는생약추출물을함유하는화장료 |
KR100561780B1 (ko) | 1999-08-23 | 2007-04-12 | 주식회사 엘지생활건강 | 탱자 추출물을 함유하는 항자극용 화장료 조성물 |
FR2837702B1 (fr) * | 2002-03-26 | 2005-01-14 | Clarins Lab | Composition cosmetique pour le soin de la peau plus particulierement comme soin de nuit |
JP2004083416A (ja) * | 2002-08-22 | 2004-03-18 | Takeda Food Products Ltd | 皮膚外用剤並びに飲食品 |
JP4047130B2 (ja) * | 2002-10-18 | 2008-02-13 | 株式会社ノエビア | 水性スティック状化粧料 |
KR20050024831A (ko) * | 2003-09-04 | 2005-03-11 | 주식회사 엘지생활건강 | 생약추출물을 함유하는 항염효과를 갖는 화장료 조성물 |
KR20060014714A (ko) | 2004-08-12 | 2006-02-16 | 주식회사 엘지생활건강 | 생약 추출물을 포함하는 주름 완화 화장료 조성물 |
-
2006
- 2006-07-04 FR FR0652784A patent/FR2903310B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-23 US US11/805,390 patent/US7527813B2/en not_active Expired - Fee Related
- 2007-05-31 GB GB0710320A patent/GB2439793B/en not_active Expired - Fee Related
- 2007-06-04 DE DE102007026156.1A patent/DE102007026156B4/de not_active Expired - Fee Related
- 2007-06-09 RU RU2007121769/15A patent/RU2007121769A/ru not_active Application Discontinuation
- 2007-06-19 JP JP2007160836A patent/JP5196416B2/ja not_active Expired - Fee Related
- 2007-06-25 KR KR1020070062057A patent/KR101315160B1/ko active IP Right Grant
- 2007-06-27 IT IT000462A patent/ITTO20070462A1/it unknown
- 2007-07-03 CN CNA2007101272338A patent/CN101099719A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ITTO20070462A1 (it) | 2008-01-05 |
GB2439793A (en) | 2008-01-09 |
FR2903310A1 (fr) | 2008-01-11 |
US20080031981A1 (en) | 2008-02-07 |
US7527813B2 (en) | 2009-05-05 |
JP2008013553A (ja) | 2008-01-24 |
KR20080004353A (ko) | 2008-01-09 |
RU2007121769A (ru) | 2008-12-20 |
CN101099719A (zh) | 2008-01-09 |
FR2903310B1 (fr) | 2008-10-17 |
GB2439793B (en) | 2009-01-28 |
GB0710320D0 (en) | 2007-07-11 |
KR101315160B1 (ko) | 2013-10-08 |
DE102007026156B4 (de) | 2015-10-29 |
DE102007026156A1 (de) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH698274B1 (de) | Komplex aktiver pflanzlicher Stammzellen und kosmetische Komposition. | |
JP5196416B2 (ja) | Limnocitruslittoralis抽出物を含有する化粧料組成物 | |
KR20070002409A (ko) | 문형 추출물을 유효성분으로 함유하는 화장료 조성물 | |
JP5626650B2 (ja) | ラン抽出物を含有する化粧品用組成物 | |
JPH11147834A (ja) | セリンプロテアーゼ阻害剤 | |
JP2006241148A (ja) | コラゲナーゼ阻害剤及び老化防止用皮膚外用剤 | |
JP2003201214A (ja) | マトリックスメタロプロテアーゼ活性阻害剤 | |
JPH05501108A (ja) | 皮膚色素形成コレウス抽出物含有組成物 | |
JP4768097B2 (ja) | 活性酸素消去剤、血小板凝集抑制剤、皮膚化粧料および浴用剤 | |
JP4906179B2 (ja) | 皮膚外用剤 | |
JPH06336421A (ja) | 皮膚外用剤 | |
JP3496967B2 (ja) | 抗プラスミン剤 | |
JPH07126143A (ja) | 化粧料 | |
JP2000212058A (ja) | 皮膚化粧料、活性酸素消去剤、エラスタ―ゼ阻害剤およびコラゲナ―ゼ阻害剤 | |
KR940006066B1 (ko) | 피부화장료 | |
JP3113009B2 (ja) | 美白化粧料 | |
KR20210068936A (ko) | 천연물을 포함하는 아토피성 피부 개선 및 피부 보습용 조성물 | |
US20050037028A1 (en) | Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient | |
JP2002053477A (ja) | 皮膚外用剤 | |
US10953066B2 (en) | Compositions for the treatment of chronic ulcers | |
JP7402478B2 (ja) | 神経成長因子発現抑制剤およびセマフォリン3a発現促進剤 | |
KR100967805B1 (ko) | 새우나무 잎 추출물을 포함하는 피부주름 개선용 화장료조성물 | |
KR102610940B1 (ko) | 피부 미용액을 이용한 화장료 조성물의 제조방법 | |
KR101137086B1 (ko) | 혼합이성화당과 은행잎 추출물을 함유하는 피부 외용제조성물 | |
WO2021133307A1 (en) | Cosmetic formulation containing the smoke tree extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080410 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20080417 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080602 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080610 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100415 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121030 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130130 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160215 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5196416 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |